Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)

NCT03530332 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1208

Last updated 2020-02-17

No results posted yet for this study

Summary

This research study is being done to find out whether a screening blood test can help identify women with an increased risk of preterm birth.

Conditions

Interventions

DIAGNOSTIC_TEST

PreTRM test

Blood test to determine risk of preterm birth

Sponsors & Collaborators

  • Sera Prognostics, Inc.

    collaborator INDUSTRY
  • Ware Branch

    lead OTHER

Principal Investigators

  • Ware Branch, M.D. · Intermountain Health Care, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-14
Primary Completion
2019-02-17
Completion
2019-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03530332 on ClinicalTrials.gov